Mylan N.V. (NASDAQ:MYL)‘s stock had its “overweight” rating reaffirmed by investment analysts at J P Morgan Chase & Co in a report issued on Friday. They currently have a $48.00 price target on the stock, up from their previous price target of $44.00. J P Morgan Chase & Co’s target price suggests a potential upside of 25.39% from the company’s previous close.

Other equities analysts have also issued reports about the stock. Cowen and Company restated a “hold” rating and issued a $30.00 price objective (down from $43.00) on shares of Mylan N.V. in a report on Wednesday, August 9th. Royal Bank Of Canada restated a “sector perform” rating and issued a $32.00 price objective (down from $33.00) on shares of Mylan N.V. in a report on Thursday, August 10th. Citigroup Inc. upgraded shares of Mylan N.V. from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $36.00 to $42.00 in a report on Wednesday, August 16th. Wells Fargo & Company set a $32.00 price objective on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Wednesday. Finally, UBS AG restated a “buy” rating and issued a $46.00 price objective on shares of Mylan N.V. in a report on Thursday. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $41.99.

Shares of Mylan N.V. (NASDAQ MYL) traded up 0.98% during trading on Friday, hitting $38.29. 6,282,197 shares of the stock were exchanged. Mylan N.V. has a one year low of $29.39 and a one year high of $45.87. The company has a market cap of $20.53 billion, a price-to-earnings ratio of 30.95 and a beta of 1.30. The stock’s 50 day moving average price is $31.86 and its 200-day moving average price is $36.48. Mylan N.V. also was the recipient of unusually large options trading activity on Wednesday. Stock investors bought 10,562 put options on the stock. This represents an increase of 461% compared to the average volume of 1,883 put options.

Mylan N.V. (NASDAQ:MYL) last issued its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.18 by ($0.08). Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the prior year, the company posted $1.16 earnings per share. The business’s revenue was up 15.7% compared to the same quarter last year. On average, analysts predict that Mylan N.V. will post $4.57 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/06/mylan-n-v-s-myl-overweight-rating-reaffirmed-at-j-p-morgan-chase-co.html.

Several large investors have recently made changes to their positions in MYL. Harvest Management purchased a new stake in shares of Mylan N.V. in the 3rd quarter valued at approximately $3,462,000. Meag Munich Ergo Kapitalanlagegesellschaft purchased a new stake in shares of Mylan N.V. in the 3rd quarter valued at approximately $3,268,000. Eagle Asset Management increased its position in shares of Mylan N.V. by 85.5% in the 3rd quarter. Eagle Asset Management now owns 752,812 shares of the company’s stock valued at $30,308,000 after purchasing an additional 347,018 shares during the last quarter. Water Island Capital increased its position in shares of Mylan N.V. by 817.9% in the 3rd quarter. Water Island Capital now owns 370,088 shares of the company’s stock valued at $14,900,000 after purchasing an additional 329,770 shares during the last quarter. Finally, Janus Capital Management increased its position in shares of Mylan N.V. by 1,608.1% in the 3rd quarter. Janus Capital Management now owns 687,099 shares of the company’s stock valued at $27,663,000 after purchasing an additional 646,874 shares during the last quarter. 71.97% of the stock is currently owned by institutional investors.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.